1160182-44-4 Usage
Uses
Used in Organic Synthesis:
4-bromo-3-(1,3-dioxolan-2-yl)phenol serves as a key building block in organic synthesis, facilitating the creation of a wide range of organic compounds. Its molecular structure allows for further functionalization and modification, enabling the development of novel chemical entities with diverse applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-bromo-3-(1,3-dioxolan-2-yl)phenol is utilized as a starting material for the development of new drugs. Its unique structure and properties make it a promising candidate for the synthesis of bioactive molecules with potential therapeutic applications.
Used in Agrochemical Development:
4-bromo-3-(1,3-dioxolan-2-yl)phenol also finds applications in the agrochemical sector, where it is employed as a precursor for the synthesis of various agrochemicals. Its molecular structure can be tailored to create compounds with specific pesticidal or herbicidal properties, contributing to the development of more effective and environmentally friendly agricultural products.
Used in Industrial Product Development:
Beyond its applications in organic synthesis, pharmaceutical research, and agrochemicals, 4-bromo-3-(1,3-dioxolan-2-yl)phenol also plays a role in the development of other industrial products. Its versatile molecular structure allows for the creation of compounds with specific properties, such as improved stability, reactivity, or selectivity, which can be beneficial in various industrial applications.
Safety Considerations:
Due to its potential hazardous and toxic nature, it is crucial to handle 4-bromo-3-(1,3-dioxolan-2-yl)phenol with caution and adhere to established safety protocols. Proper protective measures, such as wearing appropriate personal protective equipment and working in well-ventilated areas, should be taken to minimize the risk of exposure and ensure the safety of researchers and workers involved in its synthesis and use.
Check Digit Verification of cas no
The CAS Registry Mumber 1160182-44-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,0,1,8 and 2 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1160182-44:
(9*1)+(8*1)+(7*6)+(6*0)+(5*1)+(4*8)+(3*2)+(2*4)+(1*4)=114
114 % 10 = 4
So 1160182-44-4 is a valid CAS Registry Number.
1160182-44-4Relevant academic research and scientific papers
Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68)
Yu, Xufen,Huang, Xi-Ping,Kenakin, Terry P.,Slocum, Samuel T.,Chen, Xin,Martini, Michael L.,Liu, Jing,Jin, Jian
, p. 7557 - 7574 (2019/09/09)
G protein-coupled receptor 68 (GPR68) is an understudied orphan G protein-coupled receptor (GPCR). It is expressed most abundantly in the brain, potentially playing important roles in learning and memory. Pharmacological studies with GPR68 have been hinde
Boron-Containing Small Molecules as Anti-Inflammatory Agents
-
Paragraph 0623-0624, (2015/11/16)
Compounds and methods of treating anti-inflammatory conditions are disclosed.
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Akama, Tsutomu,Baker, Stephen J.,Zhang, Yong-Kang,Hernandez, Vincent,Zhou, Huchen,Sanders, Virginia,Freund, Yvonne,Kimura, Richard,Maples, Kirk R.,Plattner, Jacob J.
scheme or table, p. 2129 - 2132 (2009/12/07)
A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release. 5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo. This compound is now in clinical development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.
